Wire Stories
-
9977% of Germans Want Robots in the Workplace – automatica Trend Report 2025
MUNICH–(BUSINESS WIRE)–#AI—The vast majority of employees in Germany believe that robot deployment in factories will ensure the country’s competitiveness. Three out of...
-
99Soaring in 2025: STARLUX Celebrates Ontario-Taipei Inaugural Flight – Its 4th US Destination and 2nd Gateway in Greater L.A.
Gate launch event heralds expanded travel options from Greater Los Angeles, connecting STARLUX passengers to Taipei and onward to 24 Asian destinations...
-
89BELFOR Highlights Digital Transformation in Damage Assessment at Asia Claims Convention 2025 in Osaka
OSAKA, Japan–(BUSINESS WIRE)–#AsiaClaimsConvention2025–BELFOR, the world’s leading provider of disaster recovery and property restoration services, recently participated in the Asia Claims Convention 2025,...
-
99ROI·DNA Expands Global Footprint to Accelerate Growth for International B2B Technology Brands
Integrated team across EMEA, APAC, and North America positions ROI·DNA as the go-to growth partner for enterprise technology companies worldwide SAN FRANCISCO–(BUSINESS...
-
97Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. BELLEVUE, Neb.–(BUSINESS WIRE)–Lenovo,...
-
85Arizona Sonoran Appoints Hannam & Partners as Project Finance Advisor for the Cactus Project
CASA GRANDE, Ariz. & TORONTO–(BUSINESS WIRE)–$ASCU #Arizona—Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) is pleased to announce...
-
82KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group
Transaction marks KKR’s latest and largest credit investment in India MUMBAI, India–(BUSINESS WIRE)–KKR, a leading global investment firm, and Manipal Education and...
-
88MarkHerz Signs MOU with TUM Hospital for Joint Development of Cardiovascular and Diabetes-Targeted AAV Gene Therapies
Paving the Way for European Clinical Entry and Global Technology Transfer A Milestone Partnership Highlighting Korea’s Expanding Influence in Global Biotech Innovation...
-
81ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration...
